Filing Details

Accession Number:
0000899243-22-035725
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-14 17:43:46
Reporting Period:
2022-11-11
Accepted Time:
2022-11-14 17:43:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
730272 Repligen Corp RGEN Biological Products, (No Disgnostic Substances) (2836) 042729386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606030 Anthony Hunt C/O Repligen Corporation
41 Seyon St., Bldg 1, Ste 100
Waltham MA 02453
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-11 25,000 $33.87 203,265 No 4 M Direct
Common Stock Disposition 2022-11-11 25,000 $200.00 178,265 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2022-11-11 25,000 $0.00 25,000 $33.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,246 2028-02-29 No 4 M Direct
Footnotes
  1. Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.
  2. This option is fully vested and exercisable.